V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004667 | 310002066 | 1.6 | 74.9 | Palliative (P) | 2013-12-09 | 2013-12-22 | EOX | 2 | N | 310020286 | HYDROXYCARBAMIDE |
| 310004668 | 310002067 | null | 64 | Palliative (P) | 2014-02-11 | 2014-02-22 | Gemcitabine + Methylprednisolone | 02 | N | 310020557 | GEMCITABINE |
| 310004669 | 310002068 | 1.61 | null | Neo-adjuvant (N) | 2015-06-12 | 2015-06-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 310020845 | IMATINIB |
| 310004670 | 310002069 | 1.64 | 91 | Disease modification (D) | 2015-10-01 | 2015-10-01 | CISPLATIN + FLUOROURACIL | N | N | 310020901 | PACLITAXEL |
| 310004671 | 310002070 | 1.73 | null | Neo-adjuvant (N) | 2015-03-20 | 2015-03-27 | EOX | 02 | N | 310021040 | OXALIPLATIN + MDG |
| 310004672 | 310006876 | null | null | Palliative (P) | 2018-05-04 | 2018-05-05 | ECX | null | null | 310021103 | ECX |
| 310004673 | 310002071 | 1.62 | 114.8 | Curative (C) | 2014-07-01 | 2014-07-02 | CHOEP - 21 days | null | null | 310021173 | CHOEP |
| 310004674 | 310002071 | 0 | 65 | Curative (C) | 2016-10-28 | 2016-10-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 310021173 | EOX |
| 310004675 | 310002071 | 1.65 | 89.65 | Adjuvant (A) | 2014-08-30 | 2014-09-06 | Capecitabine + Oxaliplatin 21day | N | N | 310021173 | CAPECITABINE + CISPLATIN |
| 310004676 | 310010421 | 1.76 | 74.9 | Palliative (P) | null | 2015-04-06 | Liposomal Doxorubicin (Caelyx) | 2 | N | 310021556 | DACARBAZINE |
| 310004679 | 310002073 | 1.62 | 0 | Palliative (P) | 2013-11-24 | 2013-07-20 | IPILIMUMAB + NIVOLUMAB | N | N | 310022079 | IPILIMUMAB + NIVOLUMAB |
| 310004680 | 310002073 | 1.71 | 102.2 | Neo-adjuvant (N) | 2015-05-10 | 2015-05-13 | EOX | N | N | 310022079 | VEMURAFENIB |
| 310004681 | 310002073 | null | null | Not known (9) | 2017-07-28 | 2017-08-08 | BCG Intravesical | null | null | 310022079 | PACLITAXEL |
| 310004682 | 310002074 | 1.6 | 73 | Neo-adjuvant (N) | 2013-05-05 | 2013-05-05 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310022214 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004683 | 310002075 | 1.58 | 101.3 | Curative (C) | 2017-07-02 | 2017-07-31 | IPILIMUMAB + NIVOLUMAB | N | N | 310022286 | IPILIMUMAB + NIVOLUMAB |
| 310004684 | 310002076 | 1.72 | 68.7 | Palliative (P) | 2015-02-14 | 2015-02-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 310022650 | CAPECITABINE |
| 310004685 | 310006880 | 1.7 | null | Palliative (P) | 2013-04-01 | 2013-04-11 | Vemurafenib | N | N | 310022754 | LIPOSOMAL DOXORUBICIN |
| 310004686 | 310006880 | 1.77 | 72 | null | 2014-06-08 | 2014-06-23 | ICON8 TRIAL | N | N | 310022754 | EOX |
| 310004687 | 310002077 | 1.61 | 0 | Not known (9) | 2014-06-01 | 2014-06-02 | Dacarbazine | N | N | 310023040 | RITUXIMAB |
| 310004688 | 310002078 | 1.57 | 68.3 | Not known (9) | 2014-03-08 | 2014-03-20 | Dacarbazine | N | N | 310023145 | DACARBAZINE |
| 310004689 | 310002079 | 1.8 | 101 | Palliative (P) | 2013-10-26 | 2013-11-19 | Bevacizumab+Carbo+Pacliaxel | N | N | 310023156 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310004690 | 310002080 | null | 0 | Palliative (P) | null | 2014-03-23 | ECX | N | N | 310023158 | ECX |
| 310004691 | 310002080 | 1.55 | 63 | null | 2017-06-26 | 2017-06-29 | Bexarotene | Y | null | 310023158 | OXALIPLATIN + MDG |
| 310004692 | 310002081 | 1.6 | 40.9 | Palliative (P) | null | 2013-11-30 | CAPECITABINE + OXALIPLATIN | 2 | N | 310023172 | OXALIPLATIN + MDG |
| 310004693 | 310002081 | null | 10.3 | Disease modification (D) | 2015-06-19 | 2015-06-19 | Dacarbazine | null | null | 310023172 | CISPLATIN + FLUOROURACIL |
| 310004694 | 310002082 | 1.58 | null | Palliative (P) | 2014-05-24 | 2014-06-04 | Capecitabine | null | N | 310023183 | PACLITAXEL |
| 310004695 | 310002082 | 1.82 | null | Disease modification (D) | 2018-05-10 | 2018-05-10 | CISPLATIN + FLUOROURACIL | N | N | 310023183 | HYDROXYCARBAMIDE |
| 310004696 | 310009211 | 1.81 | null | Palliative (P) | null | 2018-01-30 | GEM-P | N | N | 310023196 | BEXAROTENE |
| 310004697 | 310009211 | 1.49 | null | null | 2014-12-26 | 2014-12-31 | CISPLATIN + FLUOROURACIL | 02 | N | 310023196 | OXALIPLATIN + MDG |
| 310004698 | 310009211 | null | null | null | null | 2014-05-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310023196 | ICON TRIAL |
| 310004699 | 310002083 | 1.5 | 56.3 | Palliative (P) | 2014-06-23 | 2014-07-03 | GEMCITABINE | N | N | 310023203 | RITUXIMAB |
| 310004700 | 310002084 | 1.73 | 66.1 | Palliative (P) | null | 2015-06-22 | Dacarbazine | null | null | 310023215 | DACARBAZINE |
| 310004701 | 310002085 | null | 122 | Disease modification (D) | 2013-06-10 | 2013-06-11 | IPILIMUMAB + NIVOLUMAB | 02 | N | 310023218 | IPILIMUMAB + NIVOLUMAB |
| 310004702 | 310002086 | 1.73 | 95.7 | Neo-adjuvant (N) | null | 2014-03-18 | ECX | N | N | 310023225 | ECX |
| 310004703 | 310002087 | null | 56.6 | Palliative (P) | 2013-08-31 | 2013-08-31 | GEMCITABINE | N | N | 310023229 | GEMCITABINE |
| 310004704 | 310002087 | null | 73.9 | Curative (C) | 2016-10-03 | 2016-10-04 | IMATINIB | null | null | 310023229 | MITOMYCIN INTRAVESICULAR |
| 310004705 | 310002087 | 1.83 | 94.4 | Curative (C) | 2014-04-26 | 2014-05-28 | null | 2 | N | 310023229 | NOT MATCHED |
| 310004706 | 310002087 | 1.71 | 84.7 | null | null | 2013-09-08 | CHOEP - 21 days | N | N | 310023229 | CHOEP |
| 310004707 | 310002087 | 1.54 | 139 | Curative (C) | 2016-03-26 | 2016-03-27 | Retinoblastoma Rel IA Melphalan | 99 | N | 310023229 | NOT MATCHED |
| 310004708 | 310002088 | null | 86.2 | Palliative (P) | 2017-07-21 | 2017-07-21 | Oxaliplatin + Modified de Gramont | N | N | 310023247 | ICON TRIAL |
| 310004709 | 310002088 | 1.76 | 66.9 | Curative (C) | 2018-02-24 | 2018-02-24 | Gemcitabine day 1&8 | N | N | 310023247 | CISPLATIN + ETOPOSIDE |
| 310004710 | 310002088 | 1.63 | 104 | Neo-adjuvant (N) | 2013-09-21 | 2013-09-28 | LIPOSOMAL DOXORUBICIN | N | N | 310023247 | BEXAROTENE |
| 310004711 | 310002089 | 1.8 | 79.8 | Curative (C) | 2015-01-15 | 2015-02-12 | NB HRNBL-1 MOD N7 CAV | 2 | N | 310023287 | NOT MATCHED |
| 310004712 | 310002090 | 1.66 | 74.1 | Palliative (P) | 2013-10-09 | 2013-10-13 | ECX | 02 | N | 310023289 | ECX |
| 310004713 | 310002090 | 1.69 | null | Not known (9) | 2017-06-20 | 2017-06-20 | MCX | 02 | N | 310023289 | CVP R |
| 310004714 | 310002091 | 1.59 | 80.2 | Adjuvant (A) | 2014-03-13 | 2014-06-27 | BEP 5 Day | null | null | 310023298 | DOCETAXEL |
| 310004715 | 310002091 | null | 80.4 | Curative (C) | 2013-08-09 | 2013-08-22 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 310023298 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN |
| 310004716 | 310002092 | 1.7 | null | Palliative (P) | null | 2018-04-25 | CARBOPLATIN + FLUOROURACIL | N | N | 310023303 | CHLORAMBUCIL |
| 310004717 | 310002092 | 1.69 | 146.9 | null | 2016-02-22 | 2016-02-29 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 310023303 | DABRAFENIB |
| 310004718 | 310002092 | 1.74 | null | Palliative (P) | 2015-11-10 | 2015-11-17 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | Y | 310023303 | CISPLATIN + VINORELBINE + RT |